Literature DB >> 11584365

Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology.

S Q Yang1, H Z Lin, A K Mandal, J Huang, A M Diehl.   

Abstract

The impaired regenerative capacity of fatty livers might promote the progression of nonalcoholic fatty liver disease (NAFLD). To identify mechanisms involved, regenerative responses were compared in normal mice and ob/ob mice (a model for NAFLD) after partial hepatectomy (PH). We hypothesized that the usual PH activation of oxidant-sensitive, growth-regulatory kinase cascades would be abnormal in fatty hepatocytes, which have adapted to chronic oxidant stress, and expected that this might interfere with the induction of proliferative- and stress-related genes. The normal coordinated induction of Jun N-terminal kinases (Jnks) and extracellular regulated kinases (Erks) does not occur after PH in ob/ob mice, which cannot activate Jnks but can superinduce Erks. Jnk inhibition is associated with enhanced activation of Akt, which inhibits phosphoenolpyruvate carboxykinase (PEPCK) induction, causing severe hypoglycemia and increased lethality in the ob/ob group. Activation of nuclear factor kappaB (NF-kappaB) is also inhibited, but liver damage is increased only modestly, perhaps because Akt-regulated survival factors are protective. Despite enhanced Erk activity, induction of cyclin D-1, an NF-kappaB target gene, is abolished and this, together with hyperphosphorylated signal transducer and activator of transcription-3 (Stat-3) and reduced adenosine triphosphate (ATP) levels, arrests fatty hepatocytes in G(1). Thus, in mice with NAFLD that have adapted hepatocyte signaling mechanisms to survive chronic oxidative stress, the cellular response to an acute regenerative stimulus is altered. This contributes to NAFLD pathophysiology by inhibiting proliferation, increasing injury, and limiting function in fatty livers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584365     DOI: 10.1053/jhep.2001.28054

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  71 in total

Review 1.  Impact of liver diseases on the development of type 2 diabetes mellitus.

Authors:  Po-Shiuan Hsieh; Yen-Ju Hsieh
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

2.  Function and volume recovery after partial hepatectomy: influence of preoperative liver function, residual liver volume, and obesity.

Authors:  Johan Friso Lock; Maciej Malinowski; Daniel Seehofer; Steffi Hoppe; Rhea Isabel Röhl; Stefan Markus Niehues; Peter Neuhaus; Martin Stockmann
Journal:  Langenbecks Arch Surg       Date:  2012-06-24       Impact factor: 3.445

3.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Authors:  Michael Charlton; Anuradha Krishnan; Kimberly Viker; Schuyler Sanderson; Sophie Cazanave; Andrea McConico; Howard Masuoko; Gregory Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

4.  Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice.

Authors:  Juergen Siebler; Markus Schuchmann; Susanne Strand; Hans A Lehr; Markus F Neurath; Peter R Galle
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

Review 5.  Cellular and molecular basis of liver regeneration.

Authors:  Sushant Bangru; Auinash Kalsotra
Journal:  Semin Cell Dev Biol       Date:  2020-01-22       Impact factor: 7.727

6.  The Influence of Liver Resection on Intrahepatic Tumor Growth.

Authors:  Hannes H Brandt; Valérie Nißler; Roland S Croner
Journal:  J Vis Exp       Date:  2016-04-09       Impact factor: 1.355

7.  Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration.

Authors:  Amanda J Hodgson; Victor V Keasler; Betty L Slagle
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

9.  Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.

Authors:  Xiaoling Jin; Teresa A Zimmers; Zongxiu Zhang; Leonidas G Koniaris
Journal:  Dig Dis Sci       Date:  2018-10-03       Impact factor: 3.199

10.  The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy.

Authors:  Stéphanie Truant; Clio Baillet; Viviane Gnemmi; Maxence Fulbert; Anthony Turpin; Sabrina Dardenne; Emmanuelle Leteurtre; Mehdi El Amrani; Sébastien Dharancy; Laurent Dubuquoy; Damien Huglo; Christophe Chesné; François-René Pruvot
Journal:  Ann Surg Oncol       Date:  2020-08-24       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.